Exchange: NASDAQ·Updated 11:40 AM EDT
IBRX logo

IBRXImmunityBio Inc

$7.46
$0.05
(0.67%)
Today
EarningsAug 4
Mkt Cap$7.87B
Vol1.71M
News
all
press releases
SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot
J&J’s fast-growing Inlexzo bladder-cancer franchise could make IBRX either strategically attractive or a direct rival.
Stocktwits
More News
IBRX Stock Climbs Premarket Despite Investor Stake Cut — Retail Sees ‘Imminent’ Global Rollout Catalyst
Sheets Smith Wealth Management cut its IBRX stake by 7.2% to 512,572 shares.
Stocktwits
Can IBRX Stock Keep Its Pulse? Institutional Investors Buy In, Retail Hopes For Big Q2 Surprise
Retail traders are watching to see whether ImmunityBio could announce preliminary Q2 revenue, with some speculating that demand for Anktiva could drive sales above $55 million.
Stocktwits
SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick
Traders are watching for the 80th event, data lock and topline results, while some are also speculating about potential M&A.
Stocktwits
IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth Catalyst
Traders remain focused on Anktiva’s potential label expansion for papillary bladder cancer, with an FDA decision date set for Jan. 6, 2027.
Stocktwits
IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 Sales
Saudi Arabia is key to the bull case after ImmunityBio launched Anktiva there for certain patients with bladder and lung cancer.
Stocktwits
ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last?
ImmunityBio (IBRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
SLS, IBRX Eye Green Month As Biotech ETF Gains Steam: Analyst Sees ‘Continued Opportunities’ In Immuno-Oncology
XBI, which includes both SLS and IBRX, is on track for its strongest monthly performance since December 2023.
Stocktwits
IBRX Stock Surges 12% On Russell 1000 Inclusion Hopes
The semi-annual reconstitution of the index, based on market capitalizations as of April 30, 2026, will take effect after the U.S. market close on Friday, June 26.
Stocktwits
Nasdaq, S&P 500 Futures Rebound As Micron Rally Lifts Chip Stocks: Why SPCX, QCOM, TSM, BABA, PLTR, CBRS, WEN, IBRX Are In Focus
Retail sentiment remained cautious, with Stocktwits data showing SPY sentiment stuck in bearish territory while QQQ sentiment improved to bullish.
Stocktwits
<
1
2
...
>

Advertisement|Remove ads.